Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;22(6):1102-5.
doi: 10.3201/eid2206.151642.

Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009-2014

Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009-2014

Felix C Ringshausen et al. Emerg Infect Dis. 2016 Jun.

Abstract

We analyzed routine statutory health insurance claim data to determine prevalence of nontuberculous mycobacterial pulmonary disease in Germany. Documented prevalence rates of this nonnotifiable disease increased from 2.3 to 3.3 cases/100,000 population from 2009 to 2014. Prevalence showed a strong association with advanced age and chronic obstructive pulmonary disease.

Keywords: Atypical mycobacterial infection; COPD; Germany; Mycobacterium avium complex; NTM-PD; bronchiectasis; chronic obstructive pulmonary disease; cystic fibrosis; international classification of diseases; nontuberculous mycobacteria; pulmonary; respiratory infections; tuberculosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trends in annual prevalence of nontuberculous mycobacterial pulmonary disease by sex and year, Germany, 2009–2014. Solid trend line indicates overall prevalence; dotted linear trend line, male prevelance; dashed linear trend line, female prevalence.
Figure 2
Figure 2
Prevalence rates of nontuberculous mycobacterial pulmonary disease, by age group, sex, and year, Germany, 2009–2014.

References

    1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. 10.1164/rccm.200604-571ST - DOI - PubMed
    1. Thomson RM. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis. 2010;16:1576–83. 10.3201/eid1610.091201 - DOI - PMC - PubMed
    1. Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42:1604–13. 10.1183/09031936.00149212 - DOI - PubMed
    1. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182:970–6. 10.1164/rccm.201002-0310OC - DOI - PMC - PubMed
    1. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012;185:881–6. 10.1164/rccm.201111-2016OC - DOI - PMC - PubMed

Publication types